Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity

Nir Arbel1, Varda Shoshan-Barmatz

  • 1Department of Life Sciences and the National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Insights

The anti-apoptotic protein Bcl-2 promotes cancer cell survival by binding to the mitochondrial protein VDAC1, inhibiting cell death. VDAC1-based peptides disrupt this interaction, potentially enhancing cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Bcl-2 family proteins are crucial regulators of apoptosis and are often overexpressed in cancers.
  • The precise mechanisms by which Bcl-2 proteins exert their antiapoptotic functions, particularly at the mitochondrial level, remain incompletely elucidated.

Purpose of the Study:

  • To investigate the interaction between the antiapoptotic protein Bcl-2 and the outer mitochondrial membrane protein VDAC1.
  • To elucidate the functional consequences of this interaction on apoptosis and to explore its therapeutic potential.

Main Methods:

  • Bicelle reconstitution assays to study direct Bcl-2 and VDAC1 interaction.
  • Site-directed mutagenesis of VDAC1 to identify interaction sites.
  • Surface plasmon resonance (SPR) to analyze peptide-Bcl-2 binding kinetics.
  • Cell-based assays using Bcl-2-GFP and VDAC1 mutants to assess apoptosis.
  • Treatment with VDAC1-based synthetic peptides to evaluate inhibition of Bcl-2-mediated survival.

Main Results:

  • Bcl-2 directly binds to VDAC1, reducing its channel conductance.
  • Specific VDAC1 sequences and residues were identified as critical for Bcl-2 interaction.
  • VDAC1-based peptides specifically bind to Bcl-2 and inhibit Bcl-2-mediated protection against apoptosis.
  • Cell-permeable VDAC1 peptides prevent Bcl-2-mediated cell survival.

Conclusions:

  • Bcl-2 promotes tumor cell survival by binding to VDAC1 on the outer mitochondrial membrane, thereby blocking cytochrome c release and apoptosis.
  • Targeting the Bcl-2-VDAC1 interaction with VDAC1-based peptides represents a potential strategy to sensitize cancer cells to chemotherapy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...